This emphasizes a critical issue as pembrolizumab is increasingly being used in early TNBC and could have long-term survivorship implications. Supported in part by The University of Texas MD Anderson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback